spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Acetyl esterase for the characterisation of glycosylation in EPO

Ludger Ltd

Acetyl esterase (sialate-O-acetylesterase) is a useful tool to remove 9-, 8- and 7-O-acetyl groups from EPO biopharmaceutical glycans

Acetyl esterase (sialate-O-acetylesterase) is a useful tool to remove 9-, 8- and 7-O-acetyl groups from EPO biopharmaceutical glycans because these sugars and their acetylation are believed to be essential factors for the function, efficacy and half-life of the drug in patients. This enzyme can also be used for the characterisation of other highly sialylated biotherapeutics such as FSH and blood clotting factors. Reference: Biochem J. 2015 Dec 1;472(2):157-67. doi: 10.1042/BJ20150388. Epub 2015 Sep 16.

A paper entitled "Analysis of three epoetin alpha products by LC and LC-MS indicates differences in glycosylation critical quality attributes, including sialic acid content" has been accepted for publication by Analytical Chemistry. This work was the result of a collaboration between the University of Reading, University of Sheffield and Ludger and acetyl esterase was used for this study. Reference: Anal Chem. 2017 Jun 9. doi: 10.1021/acs.analchem.7b00353. [Epub ahead of print] PMID: 28509534

Acetyl esterase (sialate-O-acetylesterase) is available to order from Ludger: Kit containing enzyme and buffer sufficient for 50 samples: Cat No LZ-ACASE-KIT
phone +44 (0) 1865 408 554
email info@ludger.com
web www.ludger.com
email Ludger Ltd, Culham Science Centre, Abingdon, Oxfordshire, OX14 3EB
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Charles River Announces Success of Integrated Discovery Project with ENYO Pharma

Wilmington, Mass and Lyon, France, Nov. 28, 2017 - Charles River Laboratories International, Inc. (NYSE: CRL) and ENYO Pharma SA today announced the results of a successful collaboration. Together, the companies identified the mode of action of ENYO Pharma’s lead preclinical chemical series, EYP002, using Charles River’s newly acquired, molecular target identification tool: Capture Compound Mass Spectrometry (CCMS) technology.
More info >>


White Papers

Nasal Drug Delivery with a Focus on Chronic Rhino-Sinusitis

Aptar Pharma

Aptar Pharma have hosted a scientific roundtable on “Nasal drug delivery with a focus on chronic rhino‑sinusitis”. This international scientific forum was held in Paris, France on November 13th 2012. The roundtable was organized to explore and exchange views on the science of various forms of sinusitis and its related unmet medical needs.
More info >>

Industry Events

Drug Delivery Partnerships 2018

22-24 January 2018, PGA National Resort & Spa, Palm Beach Gardens, Florida

For 22 years, DDP has been the world’s largest drug delivery meeting place to accelerate drugs to market and lengthen lifecycles for long term profitability by finding new partners, new drug delivery technologies, and new formulation development strategies.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement